Drug Discovery

Tumour microenvironment
#Cancer research #Drug discovery #Insilico Medicine #Solid tumours

First patient receives novel MAT2A inhibitor for solid tumours

The first patient has been dosed in a global multicentre clinical trial to evaluate ISM3412, a potentially best-in-class, MAT2A inhibitor with novel structure, in patients with locally advanced and metastatic solid tumours. The Phase I study consists of two parts: dose escalation and dose selection optimisation, where participants will receive… Read More

#Cancer Research #News

#Biomedical research #Drug discovery #European Union #Funding #Optibrium #Sustainability

EU-Funded PhD programme to advance sustainable drug discovery

Optibrium has partnered with Tallinn University of Technology (TalTech) to co-supervise an EU-funded PhD position as part of the INNOCHEMBIO programme1. This research project will focus on developing more accurate metabolism models that will reduce the reliance on costly laboratory experiments while improving speed, efficiency and sustainability in drug discovery. Read More

#News

#Career #Drug development #Drug discovery #England #From the top #Golden Triangle #Interview #Medicines Discovery Catapult #Nanomedicine / nanotechnology #Northern Ireland #Scotland #UK #University of Oxford

New podcast: UK Spotlight: Innovation and discovery

This is the latest episode of the free DDW narrated podcast, titled “UK Spotlight: Innovation and discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “Where is the drug discovery expertise happening in the UK?”, “From the top: Dr… Read More

#News

#Drug discovery #Events #Milner Therapeutics Institute #Novel therapeutics

Symposium showcases innovation in translational science

On 30 June 2025, The Milner Therapeutics Institute hosted its annual symposium, a hybrid event hosted at West Road Concert Hall in Cambridge, UK, to bring together leading minds from academia and industry to showcase cutting-edge research and its translation into novel therapeutics. The day featured a line-up of speakers,… Read More

#News

Seed fund
#Artificial intelligence (AI) #Drug discovery #Genetics / genomics #OutSee #Seed funding #Start-ups

Predictive genomics pioneer OutSee raises £1.8m

OutSee has secured £1.8 ($2.4) million in seed funding, led by Ahren Innovation Capital and with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures.   The funds will support OutSee through the next phase of its growth strategy, with a focus on expanding the company’s in-house… Read More

#Business & Investment #News #Start-up Zone

#Drug discovery

Guide – Accelerate your weight loss drug discovery

Explore obesity case studies profiling semaglutide, tirzepatide, and retatrutide using Eurofins Discovery’s weight-loss solutions. Advance your obesity program with on/off-target panels, translational assays, in vivo models, and MOA-reflective tools. Partner with expert scientists and program managers for strategic guidance and scientific leadership on your integrated drug discovery programs targeting weight-loss… Read More

#Guides

#Artificial intelligence (AI) #Clinical trial design #Drug discovery #Lab technology #SLAS

New DDW Highlights podcast: 30 June 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. As we announce the DDW ‘Creating cures’ programme at SLAS2026, the week’s news highlights emphasise… Read More

#News

#App note #Artificial intelligence (AI) #Drug discovery #Imaging

Your AI-enhanced solution for viral infectivity analysis

Discover how the Agilent BioTek Cytation cell imaging multimode reader and ViQi’s AVIA provide a powerful, integrated solution for viral infectivity analysis. Download the application note to explore how this innovative approach offers key advantages over traditional assays, including: High-throughput, cost-effective analysis: AVIA minimises reagent use, incubation time, and replicate needs,… Read More

#Resources

#Artificial intelligence (AI) #Clinical trial design #Drug discovery #Lab technology #SLAS

This week in drug discovery (23-27 June) 

News round-up for 23-27 June by DDW Senior Digital Content Editor Diana Spencer. As we announce the DDW ‘Creating cures’ programme at SLAS2026, the week’s news highlights emphasise the importance of advanced technologies to the success of drug discovery, including digital control arms for clinical studies, nanobody-based… Read More

#News

Trophy
#AI #Cancer research #Drug discovery #Nebius #Protein targets #Transcriptomics

Nebius accelerates next generation of AI discovery innovation

DDW’s Megan Thomas attended Nebius’ inaugural AI Discovery Awards in Amsterdam, where top prizes of $100,000 in GPU credits were awarded to four companies pioneering AI breakthroughs in cancer prediction, protein targeting, transcriptomic mapping, and precision diagnostics. The winners were selected from 257 global applications by a panel of 19… Read More

#News

#Drug development #Drug discovery #Meet the Researcher

What are the top books for life sciences researchers?

Both online and in the DDW quarterly magazine, DDW editors interview industry researchers to shine a spotlight on their work in a feature called Meet the Researcher. A question often included is: If you could make everyone read one book, article or academic paper, what would it be and… Read More

#Exclusive Content #Opinion

#DDW Turning Science into Business Symposium #Drug development #Drug discovery #Events

Secure your spot for the DDW Symposium

Register your interest for the DDW Turning Science into Business Symposium, which will take place at the Francis Crick Institute, one of Europe’s biggest biomedical labs, in London, UK in the afternoon on 4 November 2025. The half day event boasts a stellar line… Read More

#News

Ultrasonic microfluidic device
#Drug discovery #Microfluidics #Regenerative Medicine #University of Queensland

‘Smart’ microgel droplets support regenerative medicine research

Australian researchers have patented a new microfluidics tool that produces ‘smart’ microgel droplets for exploring regenerative medicines.  The platform was created by Dr Ruirui Qiao and her team at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN).  Dr Qiao said her team’s UQ-Surf microfludics platform… Read More

#News

Lab technology and automation
#Automation / robotics #Events #Lab automation #Lab technology #SLAS2026

DDW is ‘creating cures’ at SLAS2026

A series of DDW seminars based on the SLAS2026 theme of Catalyze Discovery will be available to visitors of the SLAS2026 International Conference and Exhibition (7-11 February 2026, Boston, USA). The DDW ‘Creating cures: The role of lab automation in successful drug discovery’ programme will highlight… Read More

#News

#Alzheimer's #Cellular imaging #Drug discovery #Imaging #Japan #Nanobodies #Neuroscience

Nanobody-based 3D imaging boosts neuroscience research

Scientists have created a nanobody-based method that enables ultra-fast, high-resolution 3D mapping of neurons and glia in thick brain tissues.  The researchers from Japan have developed a fast, high-sensitivity three dimensional immunohistochemistry (3D-IHC) method using nanobodies fused with peroxidase and a novel signal amplification system.  … Read More

#News